Career Development
Joe Kiani runs one of the world’s most admired medical technology companies, is an inventor of world-changing noninvasive patient monitoring devices, a trusted voice for patient safety and care, and a convention-breaking maverick.
Patient Safety and Innovation in Healthcare
featuring Joe Kiani, Founder, Chairman, and CEO, Masimo Corporation
Thursday, April 7, 2-3 p.m.
Elings 1601
Light refreshments provided
*RSVP* at: https://csep.cnsi.ucsb.edu/forms/PDS/Registration.php
Bio
Joe Kiani runs one of the world's most admired medical technology companies, is an inventor of world-changing noninvasive patient monitoring devices, a trusted voice for patient safety and care, and a convention-breaking maverick. As the founder, Chairman, and CEO of Masimo Corporation, a global medical technology innovator, Mr. Kiani has been a beacon for patient safety and innovation in healthcare for more than 20 years.
Abstract
Under his leadership, Masimo has grown from a "garage start up" into a successful publicly traded company (NASDAQ: MASI) employing more than 3,000 people worldwide and providing its market-leading Masimo SET® Measure-through Motion and Low Perfusion pulse oximetry technology to leading OEM patient monitoring manufacturers.
Convinced that the use of adaptive signal processing could solve the problems of motion artifact and signalnoise that plagued pulse oximetry, Joe Kiani founded Masimo in 1989 to improve the reliability of noninvasive patient monitoring.
Today, Masimo is an innovative powerhouse delivering key noninvasive medical breakthroughs, including:
- Rainbow Pulse CO-Oximetry™-the first blood constituent monitoring platform to measure multiple blood constituents noninvasively that previously could only be measured invasively and help clinicians reduce risky blood transfusions;
- Patient SafetyNet™-the first remote monitoring and wireless clinician notification system shown to help hospitals improve patient safety and clinical outcomes by dramatically decreasing rescue events and costly ICU transfers;
- Rainbow Acoustic MonitoringTM-the first noninvasive and continuous acoustic respiration rate (RRaTM) monitoring technology; and
- Root, the new clinical information platform, that is expected to reduce clinical distraction, complexity and cost, and accelerate innovation in patient monitoring and care.